109 related articles for article (PubMed ID: 25426196)
1. [Seven hours for effective and safe desensitization in HIV-positive patients intolerant to cotrimoxazole].
El Benaye J; Nihal B; Hicham J; Mohamed E
Pan Afr Med J; 2014; 18():238. PubMed ID: 25426196
[No Abstract] [Full Text] [Related]
2. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
[TBL] [Abstract][Full Text] [Related]
3. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
Belchi-Hernandez J; Espinosa-Parra FJ
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
[TBL] [Abstract][Full Text] [Related]
4. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
Lin D; Li WK; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
[TBL] [Abstract][Full Text] [Related]
5. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature.
Ryan C; Madalon M; Wortham DW; Graziano FM
WMJ; 1998 May; 97(5):23-7. PubMed ID: 9617304
[TBL] [Abstract][Full Text] [Related]
6. [Value of desensitization for reintroducing trimethoprim-sulfamethoxazole in hypersensitive patients with HIV infection].
Caumes E
Ann Med Interne (Paris); 1997; 148(2):172-6. PubMed ID: 9238444
[TBL] [Abstract][Full Text] [Related]
7. [Desensitization in HIV seropositive patients with cotrimoxazole hypersensitivity. A series of 18 cases].
Amedeo J; Chichmanian RM; Reboulot B; Vinti H; Rosenthal E; Pesce A; Cassuto JP
Therapie; 1994; 49(5):463-5. PubMed ID: 7855770
[No Abstract] [Full Text] [Related]
8. Treatment of Machado-Joseph disease with trimethoprim-sulphamethoxazole following successful desensitisation.
Ablin J; Elgan N
N Z Med J; 2004 Apr; 117(1191):U819. PubMed ID: 15107888
[No Abstract] [Full Text] [Related]
9. Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization.
Kardaun SH; de Waard MM; de Monchy JG
Contact Dermatitis; 2009 Jul; 61(1):50-1. PubMed ID: 19659967
[No Abstract] [Full Text] [Related]
10. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection].
Piketty C; Gilqouin J; Kazatchkine M
Ann Med Interne (Paris); 1996; 147(5):327-30. PubMed ID: 9033734
[TBL] [Abstract][Full Text] [Related]
11. [Severe metabolic acidosis in a patient treated with trimethoprim-sulfamethoxazole. Physiopathological facts].
Quintela Fandiño M; Coto López A; Fernández-Miranda C
An Med Interna; 2003 Aug; 20(8):443-4. PubMed ID: 14516274
[No Abstract] [Full Text] [Related]
12. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
[TBL] [Abstract][Full Text] [Related]
13. TMP-SMX desensitization.
Posit Aware; 1995; ():7. PubMed ID: 11362574
[TBL] [Abstract][Full Text] [Related]
14. Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations.
Soffritti S; Ricci G; Prete A; Rondelli R; Menna G; Pession A
Med Pediatr Oncol; 2003 Apr; 40(4):271-2. PubMed ID: 12555266
[No Abstract] [Full Text] [Related]
15. [Nodal nocardiosis in 2 patients with HIV infection treated with cotrimoxazole].
Valencia Ortega ME; Enríquez Crego A; Adrados de Llano M; Moreno Celda V
Rev Clin Esp; 1997 Apr; 197(4):298-9. PubMed ID: 9254409
[No Abstract] [Full Text] [Related]
16. Desensitization to co-trimoxazole in a patient with fixed drug eruption.
Patriarca G; Schiavino D; Buonomo A; Aruanno A; Altomonte G; Nucera E
J Investig Allergol Clin Immunol; 2008; 18(4):309-11. PubMed ID: 18714541
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
Perazella MA; Mahnensmith RL
Clin Nephrol; 1996 Sep; 46(3):187-92. PubMed ID: 8879854
[TBL] [Abstract][Full Text] [Related]
18. TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.
Alfirevic A; Vilar FJ; Alsbou M; Jawaid A; Thomson W; Ollier WE; Bowman CE; Delrieu O; Park BK; Pirmohamed M
Pharmacogenomics; 2009 Apr; 10(4):531-40. PubMed ID: 19374512
[TBL] [Abstract][Full Text] [Related]
19. Drug hypersensitivity in HIV.
Phillips E; Mallal S
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):324-30. PubMed ID: 17620824
[TBL] [Abstract][Full Text] [Related]
20. Balancing individual benefit against public health risk: the impact of cotrimoxazole prophylaxis in HIV-infected patients on antimicrobial resistance.
Hamer DH; Gill CJ
Am J Trop Med Hyg; 2008 Sep; 79(3):299-300. PubMed ID: 18784218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
